Yorkville Advisors is a global investment manager to private funds. The firm invests in customized structured debt and equity investments.
Business Model: B2C
Revenue: $7M
Employees: 2-10
Address: -
City: Mountainside
State: NJ
Zip: -
Country: US
Yorkville Advisors is an investment manager to private, pooled investment funds with an emphasis on financing growth companies through structured debt and equity investments. The firm was founded in 2001 by Yorkville’s President &a; Partner Mark Angelo, an alumnus of both the May Davis Group and the Boston Group. The firm provides these investments across various industries and countries. Our funds are often the sole investor in a capital raise, allowing for a controlled and disciplined exit strategy. Each of Yorkville Advisors’ transactions and investments are customized to meet the needs of the companies being invested in. Yorkville’s team has been proving growth and acquisition capital to public companies since 2001.
Contact Phone:
+12019858300
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2018 | Future Farm Technologies | Post-IPO Equity | 4M |
7/2010 | Oasmia Pharmaceutical | Post-IPO Equity | 10.2M |
3/2010 | WILEX | Post-IPO Debt | 27.1M |
8/2022 | Kinarus Therapeutics (SIX:KNRS) | Post-IPO Debt | 20.7M |
7/2014 | Medivie Therapeutics | Seed Round | 870k |
11/2022 | Faraday Future | Post-IPO Debt | 350M |
8/2022 | D-Wave Systems | Post-IPO Equity | 0 |
2/2010 | Mobile Max Technologies | Post-IPO Equity | 5M |
9/2021 | Lordstown Motors | Post-IPO Equity | 400M |
12/2020 | Kraig Biocraft Laboratories | Post-IPO Debt | 8M |
3/2010 | Resverlogix | Post-IPO Equity | 25M |
9/2022 | NioCorp | Post-IPO Debt | 81M |
5/2010 | Medicago | Post-IPO Equity | 10M |
8/2009 | TowerJazz | Post-IPO Equity | 25M |
7/2009 | VeriTeQ | Venture Round | 5M |
9/2021 | NLS Pharma | Post-IPO Equity | 2.5M |
6/2022 | Virgin Orbit | Post-IPO Debt | 50M |
2/2022 | Romeo Power | Post-IPO Equity | 350M |
5/2010 | NeoMedia Technologies | Post-IPO Equity | 10.9M |
5/2022 | Bird | Post-IPO Equity | 100M |
5/2019 | Curetis | Post-IPO Debt | 7.3M |
3/2022 | Xos Trucks | Post-IPO Equity | 125M |
4/2022 | Kraig Biocraft Laboratories | Post-IPO Equity | 1.5M |
7/2022 | Canoo | Post-IPO Equity | 250M |
3/2010 | Allon Therapeutics | Post-IPO Equity | 10M |
1/2022 | Kraig Biocraft Laboratories | Post-IPO Debt | 3M |
3/2022 | Virgin Orbit | Post-IPO Equity | 250M |
9/2009 | Hybrigenics | Post-IPO Equity | 7.3M |
1/2010 | Ashford Hospitality Trust | Post-IPO Equity | 50M |
3/2017 | MOI INC | Seed Round | 175k |
9/2010 | NeoMedia Technologies | Post-IPO Equity | 455k |
7/2022 | Canoo | Post-IPO Equity | 0 |
5/2022 | Bird | Post-IPO Equity | 0 |
4/2022 | Kraig Biocraft Laboratories | Post-IPO Equity | 0 |
3/2022 | Virgin Orbit | Post-IPO Equity | 0 |
3/2022 | Xos Trucks | Post-IPO Equity | 0 |
2/2022 | Romeo Power | Post-IPO Equity | 0 |
1/2022 | Kraig Biocraft Laboratories | Post-IPO Equity | 0 |
9/2021 | Lordstown Motors | Post-IPO Equity | 0 |
9/2021 | NLS Pharma | Post-IPO Equity | 0 |
5/2019 | Curetis | Post-IPO Debt | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|